Russia – UK: Proposal on Cooperation
On May 24-25, 2016 in Skolkovo Hypercube a workshop on development of innovative drugs will be held. Representatives of the leading pharmaceutical companies, biomedical associations, manufacturers of new drugs, contract organizations of both countries will take part in the event organized by Skolkovo Fund and UK Trade & Investment Department.
Representatives of Association of British Pharma Manufacturers of the National Center of Biological Products, Association of Clinical Investigators and Contract Developers in UK, British State Biotechnology and Healthcare Organizations will prepare their presentations.
Sponsors hope that the workshop will help establish business and academic contacts, so important for co-development of drugs of the future. Indeed, today because of changed paradigm of search of new drugs the economic efficacy of innovative activity is directly related to international approaches at all stages – from laboratory to a pharmacy counter.
Kirill Kaem, Vice-president, executive director of cluster of biomedical technologies of Skolkovo Fund, is confident that the workshop will give an impulse to new ideas and new projects, and will show new horizons for cooperation in the academic research. “Cooperation in the field of development of drugs, he says, will eventually improve access and quality of medical aid, will improve economic parameters of the healthcare system. Currently it is one of the key tasks for Russia and also for the UK”.